(Q33688775)

28 July 2017

1 reference

title

Dyslipoproteinaemia of liver disease (English)

1 reference

28 July 2017

1 reference

Miller JP

1

1 reference

28 July 2017

publication date

1 December 1990

1 reference

Bailliere's clinical endocrinology and metabolism

28 July 2017

published in

1 reference

28 July 2017

volume

4

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

807-832

1 reference

Detection of lipid transfer protein activity in rabbit liver perfusate

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Familial lecithin-cholesterol acyltransferase deficiency in four Norwegian Families. Evidence for low levels of a functionally defective enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Lipoprotein abnormalities in patients with early primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Hepatic Catabolism of Low Density Lipoprotein: Mechanisms and Metabolic Consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Increased concentration of high density lipoprotein in plasma and decreased platelet aggregation in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Plasma Cholesterol Esterification and Plasma Lipoproteins in Bile-duct-ligated Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Bile salt shift from albumin to high-density lipoprotein in cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Plasma Lecithin: Cholesterol Acyltransferase Activity in Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

High density lipoprotein subpopulations in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Role of the liver in the degradation of lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Apolipoproteins A-I, A-II and B in chronic active hepatitis and in liver cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Changes in human high density lipoproteins in patients with extra-hepatic biliary obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

An abnormal high density lipoprotein in cholestatic plasma isolated by zonal ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Treatment of pruritus of obstructive jaundice with cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Lecithin—Cholesterol Acyltransferase and the Lipoprotein Abnormalities of Parenchymal Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Plasma Lipoprotein and Apolipoprotein Profile in Alcoholic Patients with and without Liver Disease: On the Relative Roles of Alcohol and Liver Injury

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Apolipoprotein E in hepatocellular liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Hepatic chylomicron remnant (apolipoprotein E) receptors. Their physiologic and clinical importance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

The effect of ligation of the common bile duct on cholesterol synthesis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Effect of cholesterol feeding and biliary obstruction on hepatic cholesterol biosynthesis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Bile acid transport by serum lipoproteins in patients with extrahepatic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Pseudohyponatraemia, hypercholesterolaemia, and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

The cholestatic syndrome--1971.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Inhibition of hepatic triglyceride secretion and exogenous triglyceride clearance in the cholestatic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

The relationship between serum lipids and the electrophoretic pattern, with particular reference to patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Localization of the heparin-releasable lipase in situ in the rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Factors affecting the impaired hepatic uptake of chylomicron remnants in the cholestatic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Inhibition of Hepatic Chylomicron Remnant Uptake in the Cholestatic Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Familial LCAT deficiency and fish-eye disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

The hypercholesterolaemia of obstructive jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

THE LIPIDS OF SERUM AND LIVER IN PATIENTS WITH HEPATIC DISEASES.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Formation of lipoprotein-X. Its relationship to bile compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

A critical examination of the value of combined determinations of lecithin: Cholesterol acyltransferase and lipoprotein-X in the differential diagnosis of liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Hypertriglyceridaemia secondary to liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

1 reference

7 January 2021

Serum apoproteins A and B and the lecithin: cholesterol acyl transferase activities in liver cirrhosis and hepatic coma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Increased catabolism of high density lipoprotein in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Serum cholesterol precursors, cholestanol, and plant sterols in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Erythrocyte lipid composition and sodium transport in human liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Erythrocyte echinocytosis in liver disease. Role of abnormal plasma high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Lipoprotein-X: a substrate for lecithin: cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Studies on the degradation of lipoprotein-X

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

The lipid composition of serum in patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Apolipoprotein AI and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Effect of biliary obstruction on canine plasma and biliary lipids.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Identification of nascent high density lipoproteins containing arginine-rich protein in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Changes in the concentration of lipoprotein-X during incubation of postheparin plasma from patients with familial lecithin: cholesterol acyltransferase (LCAT) deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Lipoproteins in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Accelerated turnover of very low density lipoprotein triglycerides in chronic alcohol users. A possible mechanism for the up-regulation of high density lipoprotein by ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Triglyceride lipase activity in postheparin plasma and plasma lipoproteins in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Further aspects on the characterization of high and very low density lipoproteins in patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Plasma lipoproteins in liver disease. I. Immunologically distinct low-density lipoproteins in patients with biliary obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Abnormal apolipoprotein composition in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Significance of serum lipoprotein-X and gammaglutamyltranspeptidase in the diagnosis of biliary atresia. A preliminary study in 27 cholestatic young infants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Plasma ?-lipoprotein pattern in acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Xanthomatous neuropathy in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Plasma exchange for hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Effects of Intravenous Phospholipid on Low Density Lipoprotein Turnover in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Plasmaphoresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Substitution in vitro of lecithin-cholesterol acyltransferase. Analysis of changes in plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

The treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

The fusion of abnormal plasma lipoprotein (LP-X) and the erythrocyte membrane in patients with cholestasis studied by electronmicroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the ra

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Does lipoprotein-X (LP-X) act as a substrate for the lecithin: Cholesterol acyltransferase (LCAT)?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

Serum Cholesterol Esterification in Liver Disease. Combined Determinations of Lecithin: Cholesterol Acyltransferase and Lipoprotein‐X

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980080-1

7 January 2021

10.1016/S0950-351X(05)80080-1

Identifiers

DOI

1 reference

28 July 2017

1 reference